Docetaxel - Latest Advances

Expert opinion on the management of anemia in prostate cancer patients receiving PARP inhibitors.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: December 15, 2025

Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: December 15, 2025

Adenylate Uridylate- (AU-) Rich Element Gene-Based Prognostic Signature and Molecular Subtypes of Prostate Adenocarcinoma: Implications for Prognosis and Immune Microenvironment.

Journal: Archivos espanoles de urologia

Published: December 03, 2025

Correction: Synergic chemotherapeutic effects of docetaxel and carboplatin show cytotoxic and apoptotic effects in liver cancer nursing care: Role of oxidative stress and hemocompatibility.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: December 03, 2025

Targeting TROP2 Across Solid Tumors: The Clinical Profile and Role of Datopotamab Deruxtecan.

Journal: The Annals of pharmacotherapy

Published: December 01, 2025

Comparing relative dose intensity of weekly nab-paclitaxel regimens in early breast cancer: A retrospective study at a large academic outpatient cancer center.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: November 27, 2025

Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 study.

Journal: Future oncology (London, England)

Published: November 21, 2025

Premature Deaths and Life-Years Lost From Lack of Amivantamab in Brazil's Unified Health System.

Journal: JCO global oncology

Published: November 19, 2025

Lutetium Lu 177 vipivotide tetraxetan: A literature review.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: November 11, 2025

The role of gemcitabine-docetaxel in the management of NMIBC: a scoping review of current status and future directions.

Journal: Expert review of anticancer therapy

Published: November 10, 2025

Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer.

Journal: BJU international

Published: November 05, 2025

Retraction: Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.

Journal: PloS one

Published: November 05, 2025

Filters

Expert opinion on the management of anemia in prostate cancer patients receiving PARP inhibitors.

Expert opinion on the management of anemia in prostate cancer patients receiving PARP inhibitors.

Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.

Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.

Adenylate Uridylate- (AU-) Rich Element Gene-Based Prognostic Signature and Molecular Subtypes of Prostate Adenocarcinoma: Implications for Prognosis and Immune Microenvironment.

Adenylate Uridylate- (AU-) Rich Element Gene-Based Prognostic Signature and Molecular Subtypes of Prostate Adenocarcinoma: Implications for Prognosis and Immune Microenvironment.

Correction: Synergic chemotherapeutic effects of docetaxel and carboplatin show cytotoxic and apoptotic effects in liver cancer nursing care: Role of oxidative stress and hemocompatibility.

Correction: Synergic chemotherapeutic effects of docetaxel and carboplatin show cytotoxic and apoptotic effects in liver cancer nursing care: Role of oxidative stress and hemocompatibility.

Targeting TROP2 Across Solid Tumors: The Clinical Profile and Role of Datopotamab Deruxtecan.

Targeting TROP2 Across Solid Tumors: The Clinical Profile and Role of Datopotamab Deruxtecan.

Comparing relative dose intensity of weekly nab-paclitaxel regimens in early breast cancer: A retrospective study at a large academic outpatient cancer center.

Comparing relative dose intensity of weekly nab-paclitaxel regimens in early breast cancer: A retrospective study at a large academic outpatient cancer center.

Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 study.

Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 study.

Premature Deaths and Life-Years Lost From Lack of Amivantamab in Brazil's Unified Health System.

Premature Deaths and Life-Years Lost From Lack of Amivantamab in Brazil's Unified Health System.

Lutetium Lu 177 vipivotide tetraxetan: A literature review.

Lutetium Lu 177 vipivotide tetraxetan: A literature review.

The role of gemcitabine-docetaxel in the management of NMIBC: a scoping review of current status and future directions.

The role of gemcitabine-docetaxel in the management of NMIBC: a scoping review of current status and future directions.

Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer.

Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer.

Retraction: Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.

Retraction: Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.